Status
Conditions
About
assess the correlation between serum albumin levels and the severity of hepatic encephalopathy in patients with chronic liver disease.
assess the impact of albumin level on clinical course and outcomes of HE.
Full description
sample size calculation will be performed based on anticipated incidence rates of HE and variability in serum albumin levels, aiming for a study population of 100-150 patients to achieve adequate statistical power.
History of prior episodes of HE, presence of ascites, variceal bleeding, and other complications of chronic liver disease .
Age, gender, etiology of cirrhosis (e.g., viral hepatitis, alcohol), comorbid conditions (e.g., diabetes, hypertension)
Serum albumin level AST ALT Total bilirubin and direct CBC Serum creatinine Proth time and concetntration
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Loading...
Central trial contact
Hamdy S Mohamed, Assist.prof; Kerelos L Sweha, Resident
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal